Clinical Trials Directory

Trials / Unknown

UnknownNCT02232035

Diazepam at the Active Phase of Labor

Intravenous Injection of Diazepam at the Beginning of Active Phase of Labor

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Navy General Hospital, Beijing · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Prolonged labour can lead to increased maternal and neonatal mortality and morbidity due to increased risks of maternal exhaustion, postpartum haemorrhage and sepsis, fetal distress and asphyxia and requires early detection and appropriate clinical response. The risks for complications of prolonged labour are much greater in poor resource settings. Active management of labour versus physiological, expectant management, has shown to decrease the occurrence of prolonged labour. Administering sedatives during labour could also lead to faster and more effective dilatation of the cervix. Interventions to shorten labour, such as sedatives, can be used as a preventative or a treatment strategy in order to decrease the incidence of prolonged labour. As the evidence to support this is still largely anecdotal around the world. (Cochrane Database of Systematic Reviews 2013,CD009243.pub3.; Cochrane Database of Systematic Reviews 2012, CD009223.pub2.) Hypothesis: Diazepam reduced the duration of labor and the severity of pain in labor.

Conditions

Interventions

TypeNameDescription
DRUGnormal saline/diazepam at the active phase of laborA single dose intravenous injection of normal saline (2ml)/diazepam (10mg, 2ml) at the beginning of active phase of labor.

Timeline

Start date
2014-09-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2014-09-04
Last updated
2014-09-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02232035. Inclusion in this directory is not an endorsement.